In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee.
Times and Dates: 9 a.m.-5:30 p.m., March 15, 2007; 8:30 a.m.-2:30 p.m., March 16, 2007.
Place: CDC, Building 19, 1600 Clifton Road, N.E., Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The Board of Scientific Counselors, NCID, provides advice and guidance to the Director, CDC, and Director, NCID, in the following areas: program goals and objectives; strategies; program organization and resources for infectious disease prevention and control; and program priorities.
Matters To Be Discussed: Agenda items will include:
1. Breakout Group Discussions:
Vaccine Preventable Disease Surveillance
Ecology of Emerging Zoonoses and Other Infectious Diseases
Food-Borne Diseases: The New Way Forward
Working with Academic Partners
Chlamydia Screening Programs in the U.S.
Infectivity Component of Infection Control
Exotic Animal Importation and Trade
2. Coordinating Center for Infectious Diseases Updates
3. Strategies for Identifying New Pathogens
Other agenda items include announcements/introductions; follow-up on actions recommended by the Board in May 2006; consideration of future directions, goals, and recommendations.
Agenda items are subject to change as priorities dictate.
Written comments are welcome and should be received by the contact person listed below prior to the opening of the meeting.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Tony Johnson, Office of the Director, NCID, CDC, Mailstop A-45, 1600 Clifton Road, NE, Atlanta, Georgia 30333, e-mail email@example.com; telephone 404/639-3856. Start Printed Page 7660
The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.Start Signature
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. E7-2753 Filed 2-15-07; 8:45 am]
BILLING CODE 4163-18-P